A. Arcadi et al. / Journal of Organometallic Chemistry 692 (2007) 5322–5326
5325
3. Experimental
150.8, 155.7, 199.3. MS (70 EV, EI, relative intensity):
204 (M+, 96), 189 (11), 176 (24), 148 (100), 120 (54). ESI-
HRMS calculated for C13H17O2: 205.1229. Found:
205.1218%.
Temperatures are reported as bath temperature. Com-
pounds were visualized on analytical thin-layer chromato-
grams (TLC) by UV light (254 nm). The products, after
usual work-up, were purified by flash chromatography on
silica gel (230–400 mesh) eluting with n-hexane/ethyl ace-
tate mixtures. These solvents were distilled prior to use.
1H NMR and 13C NMR spectra were recorded with a Bru-
ker AC 200 E spectrometer. EI (70 eV). Mass spectra were
recorded with a Varian Saturn 2100 T GC/MS instrument
and ESI accurate mass measurements were recorded with a
Mass spectrometer Finnigan TSQ Quantum Ultra with
accurate mass options instrument. IR were recorded with
a Perkin–Elmer 683 spectrometer. Only the most signifi-
cant IR absorptions are given. All starting materials, cata-
lysts, and solvents if not otherwise stated, are commercially
available and were used as purchased, without further puri-
fication. The 2-phenylfuran 1c, was prepared by published
procedure [16]. The product 3a [17] is known and was
determined using comparison of its physical and spectral
data with those reported in the literature.
3.4. 3-(4,5-Dimethyl-furan-2-yl)-cyclohex-2-enone (3d)
IR (neat): m = 1680, 1640, 1590, 740 cmÀ1 1H NMR
.
(CDCl3, 200 MHz) d = 1.96 (s, 3H), 2.03–2.13 (m, 2H),
2.24 (s, 3H), 2.42 (t, J = 5.9 Hz, 2H), 2.57 (t, J = 6.2 Hz,
2H), 6.36 (s, 1H), 6.55 (s, 1H). 13C NMR (CDCl3,
50.3 MHz) d = 9.4, 11.4, 22.2, 24.9, 37.2, 116.3, 117.3,
118.9, 147.0, 148.9, 151.2, 198.9. MS (70 EV, EI, relative
intensity): 190 (M+, 100), 162 (60), 134 (43). ESI-HRMS
calculated for C12H15O2: 191.1072. Found: 191.1065%.
3.5. 3-(4,5-Dimethyl-furan-2-yl)-5-phenyl-cyclohex-2-enone
(3e)
1
IR (neat): m = 1695, 1625, 1580, 745 cmÀ1.; H NMR
(CDCl3, 200 MHz) d = 1.95 (s, 3H), 2.25 (s, 3H), 2.62–
2.95 (m, 4H), 3.30–3.40 (m, 1H), 6.46 (d, J = 1.7 Hz,
1H), 6.55 (s, 1H), 7.25–7.40 (m, 5H). 13C NMR (CDCl3,
50.3 MHz) d = 9.7, 11.7, 33.1, 40.6, 44.3, 116.9, 117.7,
118.8, 126.7, 127.0, 128.7, 143.3, 146.3, 148.9, 151.9,
198.6. MS (70 EV, EI, relative intensity): 267 [(M+1)+,
100]. ESI-HRMS calculated for C18H19O2: 267.1380.
Found: 267.1376%.
3.1. General procedure for the silver-catalyzed alkenylation
of 2-substituted furans 1 with cyclic 1,3-dicarbonyls (2)
To a solution of the furan derivative 1 (1 mmol) in
ClCH2CH2Cl (2 mL) were added the cyclic 1,3-dicarbonyl
compound 2 (2 mmol) and AgOTf or AgClO4 Æ H2O
(0.10 mmol). The mixture was stirred at 120 °C for the
appropriate time and monitored by TLC or GC–MS. After
completion, the solvent was removed by evaporation. The
residue was purified by chromatography on silica gel
(230–400 mesh) eluting with n-hexane/ethyl acetate mix-
tures to afford the pure derivative 3.
3.6. 3-(4,5-Dimethyl-furan-2-yl)- 5,5-dimethyl-cyclohex-2-
enone (3f)
IR (neat): m = 1700, 1640, 1580 cmÀ1. 1H NMR (CDCl3,
200 MHz) d = 1.08 (s, 6H), 1.96 (s, 2H), 2.25 (s, 3H), 2.28
(s, 3H), 2.45 (s, 2H), 6.38 (s, 1H), 6.56 (s, 1H). 13C NMR
(CDCl3, 50.3 MHz) d = 9.7, 11.7, 28.3, 33.3, 39.1, 51.2,
116.4, 117.5, 118.2, 145.1, 149.5, 151.5, 199.3. MS (70
EV, EI, relative intensity): 219 [(M+1)+, 100]. ESI-HRMS
calculated for C14H19O2: 219.1385. Found: 219.1384%.
3.2. 3-(5-Methyl-furan-2-yl)-5-phenyl-cyclohex-2-enone
(3b)
IR (neat): m = 1700, 1600, 1540, 740 cmÀ1 1H NMR
.
(CDCl3, 200 MHz) d = 2.34 (s, 3H), 2.64–2.91 (m, 4H),
3.35–3.45 (m, 1H), 6.11 (d, J = 3.3 Hz, 1H), 6.49 (d,
J = 1.9 Hz, 1H), 6.64 (d, J = 3.3 Hz, 1H), 7.26–735 (m,
5H). 13C NMR (CDCl3, 50.3 MHz) d = 33.1, 40.5, 44.2,
108.9, 114.4, 119.3, 126.7, 127.0, 128.7, 143.2, 146.2,
150.3, 156.0, 198.6. MS (70 EV, EI, relative intensity):
253 [(M+1)+, 100], 148 (43). ESI-HRMS calculated for
C17H17O2: 253.1229. Found: 253.1233%.
3.7. 3-(4,5-Dimethyl-furan-2-yl)-5-methyl-cyclohex-2-enone
(3g)
IR (neat): m = 1680, 1640, 1560 cmÀ1. 1H NMR (CDCl3,
200 MHz) d = 1.13 (d, J = 5.9 Hz, 3H), 1.96 (s, 3H), 2.10–
2.17 (m, 2H), 2.25 (s, 3H), 2.50 (d, J = 14.8 Hz, 1H), 2.70
(d, J = 13.2 Hz, 1H), 6.37 (s, 1H), 6.56 (s, 1H). 13C
NMR (CDCl3, 50.3 MHz) d = 9.7, 11.7, 21.2, 29.7, 33.4,
45.7, 116.4, 117.5, 119.0, 146.5, 149.3, 151.5, 199.5. MS
(70 EV, EI, relative intensity): 205 [(M+1)+, 100]. ESI-
HRMS calculated for C13H17O2: 205.1229. Found:
205.1217%.
3.3. 5,5-Dimethyl-3-(5-methyl-furan-2-yl)-cyclohex-2-enone
(3c)
IR (neat): m = 1710, 1595, 1540, 760 cmÀ1 1H NMR
.
(CDCl3, 200 MHz) d = 1.09 (s, 6H), 2.29 (s, 2H), 2.35 (s,
3H), 2.47 (s, 2H), 6.12 (d, J = 3.3 Hz, 1H), 6.42 (s, 1H),
6.65 (d, J = 3.3 Hz, 1H). 13C NMR (CDCl3, 50.3 MHz)
d = 13.7, 28.2, 33,3, 39.0, 51.1, 108.8, 113.9, 118.5, 145.0,
3.8. 3-(5-Phenyl-furan-2-yl)-cyclohex-2-enone (3h)
IR (neat): m = 1700, 1690, 1600, 745, 640 cmÀ1
NMR (CDCl3, 200 MHz) d = 2.05–2.19 (m, 2H), 2.49 (t,
.
1H